Ankylosing Spondylitis Drug Market Report

Global and Regional Ankylosing Spondylitis Drug Market Details Research Report 2021-2026

  • POSTDATE：Jun 29, 2021
  • PAGES：222
  • REPORT CODE：GMM744516
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Ankylosing Spondylitis Drug Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Ankylosing Spondylitis Drug market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Ankylosing Spondylitis Drug market.

    By Player:

    • Takeda

    • Wyeth

    • Pfizer

    • Schering-Plough

    • Amgen

    • Johnson & Johnson

    • Eisai

    • Mitsubishi Tanabe

    • Abbott

    • Centocor

    By Type:

    • Cimzia

    • Enbrel

    • Humira

    • Remicade

    • Simponi

    • Others

    By End-User:

    • Hospitals

    • Clinics

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Ankylosing Spondylitis Drug Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Ankylosing Spondylitis Drug Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Ankylosing Spondylitis Drug Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Ankylosing Spondylitis Drug Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Ankylosing Spondylitis Drug Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Ankylosing Spondylitis Drug Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Takeda

      • 3.1.1 Takeda - Company Business Overview

      • 3.1.2 Takeda - Company Financial Performance

      • 3.1.3 Takeda - Company Financial Performance of Ankylosing Spondylitis Drug

      • 3.1.4 Ankylosing Spondylitis Drug Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Wyeth

      • 3.2.1 Wyeth - Company Business Overview

      • 3.2.2 Wyeth - Company Financial Performance

      • 3.2.3 Wyeth - Company Financial Performance of Ankylosing Spondylitis Drug

      • 3.2.4 Ankylosing Spondylitis Drug Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Pfizer

      • 3.3.1 Pfizer - Company Business Overview

      • 3.3.2 Pfizer - Company Financial Performance

      • 3.3.3 Pfizer - Company Financial Performance of Ankylosing Spondylitis Drug

      • 3.3.4 Ankylosing Spondylitis Drug Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Schering-Plough

      • 3.4.1 Schering-Plough - Company Business Overview

      • 3.4.2 Schering-Plough - Company Financial Performance

      • 3.4.3 Schering-Plough - Company Financial Performance of Ankylosing Spondylitis Drug

      • 3.4.4 Ankylosing Spondylitis Drug Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Amgen

      • 3.5.1 Amgen - Company Business Overview

      • 3.5.2 Amgen - Company Financial Performance

      • 3.5.3 Amgen - Company Financial Performance of Ankylosing Spondylitis Drug

      • 3.5.4 Ankylosing Spondylitis Drug Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Johnson & Johnson

      • 3.6.1 Johnson & Johnson - Company Business Overview

      • 3.6.2 Johnson & Johnson - Company Financial Performance

      • 3.6.3 Johnson & Johnson - Company Financial Performance of Ankylosing Spondylitis Drug

      • 3.6.4 Ankylosing Spondylitis Drug Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Eisai

      • 3.7.1 Eisai - Company Business Overview

      • 3.7.2 Eisai - Company Financial Performance

      • 3.7.3 Eisai - Company Financial Performance of Ankylosing Spondylitis Drug

      • 3.7.4 Ankylosing Spondylitis Drug Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Mitsubishi Tanabe

      • 3.8.1 Mitsubishi Tanabe - Company Business Overview

      • 3.8.2 Mitsubishi Tanabe - Company Financial Performance

      • 3.8.3 Mitsubishi Tanabe - Company Financial Performance of Ankylosing Spondylitis Drug

      • 3.8.4 Ankylosing Spondylitis Drug Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Abbott

      • 3.9.1 Abbott - Company Business Overview

      • 3.9.2 Abbott - Company Financial Performance

      • 3.9.3 Abbott - Company Financial Performance of Ankylosing Spondylitis Drug

      • 3.9.4 Ankylosing Spondylitis Drug Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Centocor

      • 3.10.1 Centocor - Company Business Overview

      • 3.10.2 Centocor - Company Financial Performance

      • 3.10.3 Centocor - Company Financial Performance of Ankylosing Spondylitis Drug

      • 3.10.4 Ankylosing Spondylitis Drug Product Benchmarking

      • 3.10.5 Strategic Initiatives

    4 Global Ankylosing Spondylitis Drug Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Ankylosing Spondylitis Drug Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Cimzia 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Enbrel 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Humira 2016-2021

      • 4.2.4 Global Revenue and Growth Rate of Remicade 2016-2021

      • 4.2.5 Global Revenue and Growth Rate of Simponi 2016-2021

      • 4.2.6 Global Revenue and Growth Rate of Others 2016-2021

    • 4.3 Global Ankylosing Spondylitis Drug Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Cimzia 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Enbrel 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Humira 2016-2021

      • 4.3.4 Global Sales and Growth Rate of Remicade 2016-2021

      • 4.3.5 Global Sales and Growth Rate of Simponi 2016-2021

      • 4.3.6 Global Sales and Growth Rate of Others 2016-2021

    • 4.4 Global Ankylosing Spondylitis Drug Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Ankylosing Spondylitis Drug Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Ankylosing Spondylitis Drug Market Price By Type from 2016 to 2026

    5 Global Ankylosing Spondylitis Drug Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Ankylosing Spondylitis Drug

    • 5.2 Global Ankylosing Spondylitis Drug Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Hospitals 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Clinics 2016-2021

    • 5.3 Global Ankylosing Spondylitis Drug Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Hospitals 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Clinics 2016-2021

    • 5.4 Global Ankylosing Spondylitis Drug Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Ankylosing Spondylitis Drug Market Sales and Market Share by Application (Forecast)

    6 Global Ankylosing Spondylitis Drug Market Segment Analysis (Geography Level)

    • 6.1 Global Ankylosing Spondylitis Drug Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Ankylosing Spondylitis Drug Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Ankylosing Spondylitis Drug Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Ankylosing Spondylitis Drug Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Ankylosing Spondylitis Drug Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Ankylosing Spondylitis Drug Market from 2016 to 2020

    7. North America Ankylosing Spondylitis Drug Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Ankylosing Spondylitis Drug Market Segment by Countries

      • 7.1.1 North America Ankylosing Spondylitis Drug Market Revenue Segment by Countries

      • 7.1.2 North America Ankylosing Spondylitis Drug Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Ankylosing Spondylitis Drug Market Segment (Product Type Level)

    • 7.3 North America Ankylosing Spondylitis Drug Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Ankylosing Spondylitis Drug Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Ankylosing Spondylitis Drug Market Segment by Countries

      • 8.1.1 Europe Ankylosing Spondylitis Drug Market Revenue Segment by Countries

      • 8.1.2 Europe Ankylosing Spondylitis Drug Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Ankylosing Spondylitis Drug Market Segment (Product Type Level)

    • 8.3 Europe Ankylosing Spondylitis Drug Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Ankylosing Spondylitis Drug Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Ankylosing Spondylitis Drug Market Segment by Countries

      • 9.1.1 Asia Ankylosing Spondylitis Drug Market Revenue Segment by Countries

      • 9.1.2 Asia Ankylosing Spondylitis Drug Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Ankylosing Spondylitis Drug Market Segment (Product Type Level)

    • 9.3 Asia Ankylosing Spondylitis Drug Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Ankylosing Spondylitis Drug Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Ankylosing Spondylitis Drug Market Segment by Countries

      • 10.1.1 South America Ankylosing Spondylitis Drug Market Revenue Segment by Countries

      • 10.1.2 South America Ankylosing Spondylitis Drug Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Ankylosing Spondylitis Drug Market Segment (Product Type Level)

    • 10.3 South America Ankylosing Spondylitis Drug Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Ankylosing Spondylitis Drug Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Ankylosing Spondylitis Drug Market Segment by Countries

      • 11.1.1 Middle East Ankylosing Spondylitis Drug Market Revenue Segment by Countries

      • 11.1.2 Middle East Ankylosing Spondylitis Drug Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Ankylosing Spondylitis Drug Market Segment (Product Type Level)

    • 11.3 Middle East Ankylosing Spondylitis Drug Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Ankylosing Spondylitis Drug Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Ankylosing Spondylitis Drug Market Segment by Countries

      • 12.1.1 Africa Ankylosing Spondylitis Drug Market Revenue Segment by Countries

      • 12.1.2 Africa Ankylosing Spondylitis Drug Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Ankylosing Spondylitis Drug Market Segment (Product Type Level)

    • 12.3 Africa Ankylosing Spondylitis Drug Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Ankylosing Spondylitis Drug Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Ankylosing Spondylitis Drug Market Segment by Countries

      • 13.1.1 Oceania Ankylosing Spondylitis Drug Market Revenue Segment by Countries

      • 13.1.2 Oceania Ankylosing Spondylitis Drug Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Ankylosing Spondylitis Drug Market Segment (Product Type Level)

    • 13.3 Oceania Ankylosing Spondylitis Drug Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Ankylosing Spondylitis Drug Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Ankylosing Spondylitis Drug

      • 14.2.2 Manufacturing Process Analysis of Ankylosing Spondylitis Drug

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Ankylosing Spondylitis Drug Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Ankylosing Spondylitis Drug Industry Market Status, Pre-COVID-19

      • 15.5.3 Ankylosing Spondylitis Drug Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Ankylosing Spondylitis Drug Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Ankylosing Spondylitis Drug Product Picture

    • Table Ankylosing Spondylitis Drug Product Definition

    • Table Study Scope by Types

    • Figure Global Ankylosing Spondylitis Drug Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Ankylosing Spondylitis Drug Market Value by Application (2016 - 2026)

    • Figure Global Ankylosing Spondylitis Drug Market Size and Growth Rate from 2016 to 2026

    • Table Global Ankylosing Spondylitis Drug Production Capacity by Manufacturers (2016-2021)

    • Table Global Ankylosing Spondylitis Drug Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Ankylosing Spondylitis Drug Revenue by Manufacturers (2016-2021)

    • Table Global Ankylosing Spondylitis Drug Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Ankylosing Spondylitis Drug Plant Distribution and Sales Country

    • Table Takeda - Company Business Overview

    • Figure Takeda Total Revenue from 2018 to 2020

    • Table Takeda Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Takeda Sales and Growth Rate Analysis of Ankylosing Spondylitis Drug

    • Figure Revenue and Market Share Analysis of Takeda

    • Table Ankylosing Spondylitis Drug Product Benchmarking

    • Table Wyeth - Company Business Overview

    • Figure Wyeth Total Revenue from 2018 to 2020

    • Table Wyeth Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Wyeth Sales and Growth Rate Analysis of Ankylosing Spondylitis Drug

    • Figure Revenue and Market Share Analysis of Wyeth

    • Table Ankylosing Spondylitis Drug Product Benchmarking

    • Table Pfizer - Company Business Overview

    • Figure Pfizer Total Revenue from 2018 to 2020

    • Table Pfizer Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Pfizer Sales and Growth Rate Analysis of Ankylosing Spondylitis Drug

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Ankylosing Spondylitis Drug Product Benchmarking

    • Table Schering-Plough - Company Business Overview

    • Figure Schering-Plough Total Revenue from 2018 to 2020

    • Table Schering-Plough Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Schering-Plough Sales and Growth Rate Analysis of Ankylosing Spondylitis Drug

    • Figure Revenue and Market Share Analysis of Schering-Plough

    • Table Ankylosing Spondylitis Drug Product Benchmarking

    • Table Amgen - Company Business Overview

    • Figure Amgen Total Revenue from 2018 to 2020

    • Table Amgen Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Amgen Sales and Growth Rate Analysis of Ankylosing Spondylitis Drug

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Ankylosing Spondylitis Drug Product Benchmarking

    • Table Johnson & Johnson - Company Business Overview

    • Figure Johnson & Johnson Total Revenue from 2018 to 2020

    • Table Johnson & Johnson Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Johnson & Johnson Sales and Growth Rate Analysis of Ankylosing Spondylitis Drug

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Ankylosing Spondylitis Drug Product Benchmarking

    • Table Eisai - Company Business Overview

    • Figure Eisai Total Revenue from 2018 to 2020

    • Table Eisai Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Eisai Sales and Growth Rate Analysis of Ankylosing Spondylitis Drug

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Ankylosing Spondylitis Drug Product Benchmarking

    • Table Mitsubishi Tanabe - Company Business Overview

    • Figure Mitsubishi Tanabe Total Revenue from 2018 to 2020

    • Table Mitsubishi Tanabe Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Mitsubishi Tanabe Sales and Growth Rate Analysis of Ankylosing Spondylitis Drug

    • Figure Revenue and Market Share Analysis of Mitsubishi Tanabe

    • Table Ankylosing Spondylitis Drug Product Benchmarking

    • Table Abbott - Company Business Overview

    • Figure Abbott Total Revenue from 2018 to 2020

    • Table Abbott Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Abbott Sales and Growth Rate Analysis of Ankylosing Spondylitis Drug

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Ankylosing Spondylitis Drug Product Benchmarking

    • Table Centocor - Company Business Overview

    • Figure Centocor Total Revenue from 2018 to 2020

    • Table Centocor Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Centocor Sales and Growth Rate Analysis of Ankylosing Spondylitis Drug

    • Figure Revenue and Market Share Analysis of Centocor

    • Table Ankylosing Spondylitis Drug Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Ankylosing Spondylitis Drug Market Revenue by Types (Historical)

    • Table Global Ankylosing Spondylitis Drug Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Cimzia 2016-2021

    • Figure Global Revenue and Growth Rate of Enbrel 2016-2021

    • Figure Global Revenue and Growth Rate of Humira 2016-2021

    • Figure Global Revenue and Growth Rate of Remicade 2016-2021

    • Figure Global Revenue and Growth Rate of Simponi 2016-2021

    • Figure Global Revenue and Growth Rate of Others 2016-2021

    • Table Global Ankylosing Spondylitis Drug Market Sales by Types (Historical)

    • Table Global Ankylosing Spondylitis Drug Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Cimzia 2016-2021

    • Figure Global Sales and Growth Rate of Enbrel 2016-2021

    • Figure Global Sales and Growth Rate of Humira 2016-2021

    • Figure Global Sales and Growth Rate of Remicade 2016-2021

    • Figure Global Sales and Growth Rate of Simponi 2016-2021

    • Figure Global Sales and Growth Rate of Others 2016-2021

    • Table Global Ankylosing Spondylitis Drug Market Revenue by Types (Forecast)

    • Table Global Ankylosing Spondylitis Drug Market Revenue Market Share by Types (Forecast)

    • Table Global Ankylosing Spondylitis Drug Market Sales by Types (Forecast)

    • Table Global Ankylosing Spondylitis Drug Market Sales Market Share by Types (Forecast)

    • Figure Global Ankylosing Spondylitis Drug Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Ankylosing Spondylitis Drug

    • Table Global Ankylosing Spondylitis Drug Market Revenue by Application (Historical)

    • Table Global Ankylosing Spondylitis Drug Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Hospitals 2016-2021

    • Figure Global Revenue and Growth Rate of Clinics 2016-2021

    • Table Global Ankylosing Spondylitis Drug Market Sales by Application (Historical)

    • Table Global Ankylosing Spondylitis Drug Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Hospitals 2016-2021

    • Figure Global Sales and Growth Rate of Clinics 2016-2021

    • Table Global Ankylosing Spondylitis Drug Market Revenue by Application (Forecast)

    • Table Global Ankylosing Spondylitis Drug Market Revenue Market Share by Application (Forecast)

    • Table Global Ankylosing Spondylitis Drug Market Sales by Application (Forecast)

    • Table Global Ankylosing Spondylitis Drug Market Sales Market Share by Application (Forecast)

    • Table Global Ankylosing Spondylitis Drug Market Revenue by Geography (Historical)

    • Table Global Ankylosing Spondylitis Drug Market Revenue Market Share by Geography (Historical)

    • Figure Global Ankylosing Spondylitis Drug Revenue Market Share by Geography in 2020

    • Table Global Ankylosing Spondylitis Drug Market Sales by Geography (Historical)

    • Table Global Ankylosing Spondylitis Drug Market Sales Market Share by Geography (Historical)

    • Figure Global Ankylosing Spondylitis Drug Sales Market Share by Geography in 2020

    • Table Global Ankylosing Spondylitis Drug Market Revenue by Geography (Forecast)

    • Table Global Ankylosing Spondylitis Drug Market Revenue Market Share by Geography (Forecast)

    • Table Global Ankylosing Spondylitis Drug Market Sales by Geography (Forecast)

    • Table Global Ankylosing Spondylitis Drug Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Ankylosing Spondylitis Drug Revenue by Countries from 2016 to 2026

    • Table North America Ankylosing Spondylitis Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Ankylosing Spondylitis Drug Revenue Market Share by Major Countries in 2020

    • Table North America Ankylosing Spondylitis Drug Sales by Countries from 2016 to 2026

    • Table North America Ankylosing Spondylitis Drug Sales Market Share by Countries from 2016 to 2026

    • Figure North America Ankylosing Spondylitis Drug Sales Market Share by Major Countries in 2020

    • Figure USA Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure USA Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Table North America Ankylosing Spondylitis Drug Sales by Types from 2016 to 2026

    • Table North America Ankylosing Spondylitis Drug Sales Market Share by Types from 2016 to 2026

    • Table North America Ankylosing Spondylitis Drug Value by Types from 2016 to 2026

    • Table North America Ankylosing Spondylitis Drug Value Market Share by Types from 2016 to 2026

    • Table North America Ankylosing Spondylitis Drug Sales by Application from 2016 to 2026

    • Table North America Ankylosing Spondylitis Drug Sales Market Share by Application from 2016 to 2026

    • Table North America Ankylosing Spondylitis Drug Value by Application from 2016 to 2026

    • Table North America Ankylosing Spondylitis Drug Value Market Share by Application from 2016 to 2026

    • Table Europe Ankylosing Spondylitis Drug Revenue by Countries from 2016 to 2026

    • Table Europe Ankylosing Spondylitis Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Ankylosing Spondylitis Drug Revenue Market Share by Major Countries in 2020

    • Table Europe Ankylosing Spondylitis Drug Sales by Countries from 2016 to 2026

    • Table Europe Ankylosing Spondylitis Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Ankylosing Spondylitis Drug Sales Market Share by Major Countries in 2020

    • Figure Germany Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure France Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure France Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Ankylosing Spondylitis Drug Sales by Types from 2016 to 2026

    • Table Europe Ankylosing Spondylitis Drug Sales Market Share by Types from 2016 to 2026

    • Table Europe Ankylosing Spondylitis Drug Value by Types from 2016 to 2026

    • Table Europe Ankylosing Spondylitis Drug Value Market Share by Types from 2016 to 2026

    • Table Europe Ankylosing Spondylitis Drug Sales by Application from 2016 to 2026

    • Table Europe Ankylosing Spondylitis Drug Sales Market Share by Application from 2016 to 2026

    • Table Europe Ankylosing Spondylitis Drug Value by Application from 2016 to 2026

    • Table Europe Ankylosing Spondylitis Drug Value Market Share by Application from 2016 to 2026

    • Table Asia Ankylosing Spondylitis Drug Revenue by Countries from 2016 to 2026

    • Table Asia Ankylosing Spondylitis Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Ankylosing Spondylitis Drug Revenue Market Share by Major Countries in 2020

    • Table Asia Ankylosing Spondylitis Drug Sales by Countries from 2016 to 2026

    • Table Asia Ankylosing Spondylitis Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Ankylosing Spondylitis Drug Sales Market Share by Major Countries in 2020

    • Figure China Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure China Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure India Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure India Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Ankylosing Spondylitis Drug Sales by Types from 2016 to 2026

    • Table Asia Ankylosing Spondylitis Drug Sales Market Share by Types from 2016 to 2026

    • Table Asia Ankylosing Spondylitis Drug Value by Types from 2016 to 2026

    • Table Asia Ankylosing Spondylitis Drug Value Market Share by Types from 2016 to 2026

    • Table Asia Ankylosing Spondylitis Drug Sales by Application from 2016 to 2026

    • Table Asia Ankylosing Spondylitis Drug Sales Market Share by Application from 2016 to 2026

    • Table Asia Ankylosing Spondylitis Drug Value by Application from 2016 to 2026

    • Table Asia Ankylosing Spondylitis Drug Value Market Share by Application from 2016 to 2026

    • Table South America Ankylosing Spondylitis Drug Revenue by Countries from 2016 to 2026

    • Table South America Ankylosing Spondylitis Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Ankylosing Spondylitis Drug Revenue Market Share by Major Countries in 2020

    • Table South America Ankylosing Spondylitis Drug Sales by Countries from 2016 to 2026

    • Table South America Ankylosing Spondylitis Drug Sales Market Share by Countries from 2016 to 2026

    • Figure South America Ankylosing Spondylitis Drug Sales Market Share by Major Countries in 2020

    • Figure Brazil Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Table South America Ankylosing Spondylitis Drug Sales by Types from 2016 to 2026

    • Table South America Ankylosing Spondylitis Drug Sales Market Share by Types from 2016 to 2026

    • Table South America Ankylosing Spondylitis Drug Value by Types from 2016 to 2026

    • Table South America Ankylosing Spondylitis Drug Value Market Share by Types from 2016 to 2026

    • Table South America Ankylosing Spondylitis Drug Sales by Application from 2016 to 2026

    • Table South America Ankylosing Spondylitis Drug Sales Market Share by Application from 2016 to 2026

    • Table South America Ankylosing Spondylitis Drug Value by Application from 2016 to 2026

    • Table South America Ankylosing Spondylitis Drug Value Market Share by Application from 2016 to 2026

    • Table Middle East Ankylosing Spondylitis Drug Revenue by Countries from 2016 to 2026

    • Table Middle East Ankylosing Spondylitis Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Ankylosing Spondylitis Drug Revenue Market Share by Major Countries in 2020

    • Table Middle East Ankylosing Spondylitis Drug Sales by Countries from 2016 to 2026

    • Table Middle East Ankylosing Spondylitis Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Ankylosing Spondylitis Drug Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Ankylosing Spondylitis Drug Sales by Types from 2016 to 2026

    • Table Middle East Ankylosing Spondylitis Drug Sales Market Share by Types from 2016 to 2026

    • Table Middle East Ankylosing Spondylitis Drug Value by Types from 2016 to 2026

    • Table Middle East Ankylosing Spondylitis Drug Value Market Share by Types from 2016 to 2026

    • Table Middle East Ankylosing Spondylitis Drug Sales by Application from 2016 to 2026

    • Table Middle East Ankylosing Spondylitis Drug Sales Market Share by Application from 2016 to 2026

    • Table Middle East Ankylosing Spondylitis Drug Value by Application from 2016 to 2026

    • Table Middle East Ankylosing Spondylitis Drug Value Market Share by Application from 2016 to 2026

    • Table Africa Ankylosing Spondylitis Drug Revenue by Countries from 2016 to 2026

    • Table Africa Ankylosing Spondylitis Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Ankylosing Spondylitis Drug Revenue Market Share by Major Countries in 2020

    • Table Africa Ankylosing Spondylitis Drug Sales by Countries from 2016 to 2026

    • Table Africa Ankylosing Spondylitis Drug Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Ankylosing Spondylitis Drug Sales Market Share by Major Countries in 2020

    • Figure Nigeria Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Ankylosing Spondylitis Drug Sales by Types from 2016 to 2026

    • Table Africa Ankylosing Spondylitis Drug Sales Market Share by Types from 2016 to 2026

    • Table Africa Ankylosing Spondylitis Drug Value by Types from 2016 to 2026

    • Table Africa Ankylosing Spondylitis Drug Value Market Share by Types from 2016 to 2026

    • Table Africa Ankylosing Spondylitis Drug Sales by Application from 2016 to 2026

    • Table Africa Ankylosing Spondylitis Drug Sales Market Share by Application from 2016 to 2026

    • Table Africa Ankylosing Spondylitis Drug Value by Application from 2016 to 2026

    • Table Africa Ankylosing Spondylitis Drug Value Market Share by Application from 2016 to 2026

    • Table Oceania Ankylosing Spondylitis Drug Revenue by Countries from 2016 to 2026

    • Table Oceania Ankylosing Spondylitis Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Ankylosing Spondylitis Drug Revenue Market Share by Major Countries in 2020

    • Table Oceania Ankylosing Spondylitis Drug Sales by Countries from 2016 to 2026

    • Table Oceania Ankylosing Spondylitis Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Ankylosing Spondylitis Drug Sales Market Share by Major Countries in 2020

    • Figure Australia Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Ankylosing Spondylitis Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Ankylosing Spondylitis Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Ankylosing Spondylitis Drug Sales by Types from 2016 to 2026

    • Table Oceania Ankylosing Spondylitis Drug Sales Market Share by Types from 2016 to 2026

    • Table Oceania Ankylosing Spondylitis Drug Value by Types from 2016 to 2026

    • Table Oceania Ankylosing Spondylitis Drug Value Market Share by Types from 2016 to 2026

    • Table Oceania Ankylosing Spondylitis Drug Sales by Application from 2016 to 2026

    • Table Oceania Ankylosing Spondylitis Drug Sales Market Share by Application from 2016 to 2026

    • Table Oceania Ankylosing Spondylitis Drug Value by Application from 2016 to 2026

    • Table Oceania Ankylosing Spondylitis Drug Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Ankylosing Spondylitis Drug

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Ankylosing Spondylitis Drug with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US